| Literature DB >> 35280594 |
Muhammad Umar Ijaz1, Muhammad Sarmad Shahab2, Abdul Samad1, Asma Ashraf3, Khalid Al-Ghanim4, Satyanarayana Swamy Mruthinti5, Shahid Mahboob4.
Abstract
Bisphenol A (BPA) is an industrial toxicant that can potentially damage the liver. Tangeretin (TGN) is a natural flavonoid that displays various pharmacological activities. This experiment was carried out to evaluate the protective effects of TGN against BPA-induced hepatic impairment in the male albino rat. Twenty-four male albino rats were equally divided into four different groups: control, BPA (100 mg/kg), BPA + TGN (100 mg/kg + 50 mg/kg) and TGN (50 mg/kg). BPA exposure significantly decreased the activities of catalase (CAT), superoxidase dismutase (SOD), peroxidase (POD), glutathione reductase (GSR), glutathione S-transferase (GST), and glutathione (GSH) content while substantially increasing the thiobarbituric acid reactive substances (TBARS) and hydrogen peroxide (H2O2) levels. A substantial increase in the levels of alanine aminotransferase (ALT), alkaline phosphatase (ALP), aspartate aminotransferase (AST) was also observed in BPA treated rats. Moreover, BPA significantly increased the inflammatory markers, including tumor necrosis factor-α (TNF-α), nuclear factor kappa-B (NF-κB), Interleukin-6 (IL-6), Interleukin-1β (IL-1β)levels, cyclooxygenase-2 (COX-2) activity, and histopathological damages. However, co-treatment with TGN efficiently minimized the BPA-induced biochemical, inflammatory, and histopathological impairments in rat liver. The present study shows that TNG has significant potential to avert BPA-induced liver damage to its antioxidant and anti-inflammatory properties.Entities:
Keywords: Bisphenol A; Environmental toxicant; Flavonoid; Hepatotoxicity; Tangeretin
Year: 2021 PMID: 35280594 PMCID: PMC8913407 DOI: 10.1016/j.sjbs.2021.11.007
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.219
The effect of TGN on CAT, SOD, POD, GSR GST, and GSH activities against BPA induced hepatotoxicity in rats.
| Groups | ||||||
|---|---|---|---|---|---|---|
| 7.90 ± 0.30a | 6.41 ± 0.12a | 5.45 ± 0.18a | 3.40 ± 0.16a | 21.06 ± 1.20a | 15.32 ± 0.45a | |
| 4.18 ± 0.22b | 2.94 ± 0.12b | 2.42 ± 0.15b | 1.82 ± 0.09b | 11.19 ± 0.61b | 8.02 ± 0.29b | |
| 7.13 ± 0.22a | 5.78 ± 0.20c | 5.18 ± 0.13a | 2.75 ± 0.23c | 18.22 ± 0.54c | 14.35 ± 0.18c | |
| 7.84 ± 0.36a | 6.40 ± 0.16a | 5.52 ± 0.19a | 3.32 ± 0.24a | 21.53 ± 0.84a | 15.70 ± 0.50a |
Values in the same column that do not share a superscript are significantly different.
The effect of TGN on TBARS and H2O2 levels in rat liver after BPA exposure.
| 13.87 ± 0.34a | 1.36 ± 0.10a | |
| 25.35 ± 1.06b | 4.15 ± 0.11b | |
| 17.95 ± 1.30c | 2.30 ± 0.15c | |
| 14.43 ± 0.56a | 1.48 ± 0.12a |
Values in the same column that do not share a superscript are significantly different.
TGN on serum markers of the liver (ALT, ALP, and AST) in rats against BPA administration.
| 43.24 ± 1.80a | 58.73 ± 2.83a | 75.31 ± 2.35a | |
| 132.6 ± 7.35b | 221.7 ± 5.90b | 136.6 ± 5.13b | |
| 75.03 ± 3.28c | 82.66 ± 3.63c | 94.61 ± 2.89c | |
| 50.52 ± 3.51ac | 66.77 ± 5.19ac | 76.48 ± 3.79a |
Values in the same column that do not share a superscript are significantly different.
TGN on inflammatory parameters (NF-κB, TNF-α, IL-1β, IL-6 levels, and COX-2 activities) in the liver of BPA-administered rats.
| 15.7 ± 0.27a | 7.29 ± 0.26a | 25.2 ± 0.32a | 6.01 ± 0.20a | 26.5 ± 1.25a | |
| 68.7 ± 1.69b | 15.9 ± 0.44b | 84.3 ± 1.88b | 19.2 ± 0.44b | 76.9 ± 3.67b | |
| 28.1 ± 0.79c | 8.29 ± 0.27c | 36.0 ± 1.53c | 7.59 ± 0.29c | 39.9 ± 1.33c | |
| 15.2 ± 0.27a | 6.85 ± 0.23a | 23.9 ± 0.59a | 5.92 ± 0.20a | 25.9 ± 1.26a |
Values in the same column that do not share a superscript are significantly different.
Fig. 1Light microscopy of liver tissues was obtained from different groups (H&E 40X). (A): Control (normal histoarchitecture). (B): BPA (100 mg/kg.); Tissues showing extensive and marked necrosis. (C): BPA (100 mg/kg) + TGN (50 mg/kg); decrease in necrosis throughout the liver tissues and recovery of damaged tissues. (D): Treatment with TGN (50 mg/kg); normal histoarchitecture almost as in control group. CV; Central venule. H; Hepatocytes. KC; Kupffer cells. S; Sinusoids. N; Nucleus.